>

Hooman Hakami - Medtronic Plc President

<div class='circular--portrait' style='background:#8A0CCF;color: white;font-size:4em;padding-top: 25px;;'>ME</div>
MDT -- USA Stock  

Earnings Report: May 28, 2020  

  President
Mr. Hooman C. Hakami is an Executive Vice President and Group President of the Diabetes Group., subsidiary of the Company since January 2015 and of Medtronic, Inc. since June 2014. Prior to that, he was President and Chief Executive Officer of Detection and Guidance Solutions at GE Healthcare from April 2012 to May 2014. Prior to that, he served as President and Chief Executive Officer of Interventional Systems from July 2009 to April 2012 Global Business Transformation leader for GE Healthcare from December 2008 to July 2009 and Vice President and General Manager, Global Ultrasound Services from June 2004 to December 2008
Age: 48  President Since 2015      
353 1 438 1700  http://www.medtronic.com
Hakami started his career with GE and has held the following financial roles: Chief Financial Officer for the Global Ultrasound division from 2001 to 2004; Chief Financial Officer for Clinical and Multivendor Services from 1999 to 2001; as well as various finance roles at GE Capital from 1994 to 1999; GE Aerospace Division from 1992 to 1994 and GE Power Systems from 1991 to 1992.

Hooman Hakami Latest Insider Activity

Management Efficiency

The company has 27.24 B in debt with debt to equity (D/E) ratio of 53.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Medtronic plc has Current Ratio of 2.62 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

JeanLuc LemercierEdwards Lifesciences Corporatio
2017
Scott UllemEdwards Lifesciences Corporatio
2014
Bernard ZovighianEdwards Lifesciences Corporatio
2016
Steven OklandSecond Sight Medical Products
2016
Larry WoodEdwards Lifesciences Corporatio
2018
Robert CardonDynatronics Corporation
2007
Brad GreathouseENCISION INC
2014
David JacquesSecond Sight Medical Products
2017
Donald BoboEdwards Lifesciences Corporatio
2015
Douglas SampsonDynatronics Corporation
2009
Martin ShirleyDigirad Corporation
2016
Peter GearyENCISION INC
2017
Stephen OklandSecond Sight Medical Products
2018
Eddie OliveiraEstablishment Labs Holdings
2016
Alberto QuesadaEstablishment Labs Holdings
2017
David EricksonEdwards Lifesciences Corporatio
N/A
Thomas GephartDynatronics Corporation
2016
Catherine SzymanEdwards Lifesciences Corporatio
2015
Huimin WangEdwards Lifesciences Corporatio
2010
Frank VandeputteSecond Sight Medical Products
2017
James OgilvieDynatronics Corporation
2016

Company Summary

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. Medtronic Plc operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 90000 people.Medtronic plc (MDT) is traded on BATS Exchange in USA. It is located in 20 On Hatch and employs 90,000 people. Medtronic Plc is listed under Medical Equipment category by Fama And French industry classification.

Medtronic plc Leadership Team

Bradley Lerman, Senior Vice President General Counsel, Corporate secretaryView
Scott Donnelly, Independent DirectorView
Richard Anderson, Lead Independent DirectorView
Ryan Weispfenning, Vice President - Investor RelationsView
Hooman Hakami, Executive Vice President and Group President of the Medtronic Diabetes GroupView
Elizabeth Nabel, Independent DirectorView
Richard Kuntz, Senior Vice President and Chief Scientific, Clinical and Regulatory OfficerView
James Lenehan, Independent DirectorView
Shirley Jackson, Independent DirectorView
Robert White, Executive Vice President and President of Medtronic?s Minimally Invasive Therapies GroupView
Preetha Reddy, Independent DirectorView
Craig Arnold, Independent DirectorView
Robert Pozen, Independent DirectorView
Kendall Powell, Lead Independent DirectorView
Bryan Hanson, Executive VP and Group President of Minimally Invasive Therapies GroupView
Denise OLeary, Independent DirectorView
Omar Ishrak, Chairman of the Board, Chief Executive OfficerView
Gary Ellis, CFO and Executive VPView
Carol Surface, Chief Human Resource Officer, Senior Vice PresidentView
Karen Parkhill, Chief Financial Officer, Executive Vice PresidentView
Geoff Martha, Executive Vice President and President - Restorative Therapies GroupView
Michael Leavitt, Independent DirectorView
Geoffrey Martha, Executive Vice President and President - Restorative Therapies GroupView
Randall Hogan, Independent DirectorView
Andrea Goldsmith, Independent DirectorView
Robert Hoedt, Executive Vice President and President - EMEACView
Michael Coyle, Executive Vice President, Group President - Cardiac and Vascular GroupView

Stock Performance Indicators

Did you try this?

Run Analyst Recommendations Now

   

Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally see Stocks Correlation. Please also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.